Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-β 1 in Peyronie's disease
- 26 July 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 295 (4), 1014-1019
- https://doi.org/10.1016/s0006-291x(02)00765-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Connective tissue growth factor: A new and important player in the pathogenesis of fibrosisCurrent Rheumatology Reports, 2002
- Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesisCurrent Opinion in Rheumatology, 2001
- New advances in Peyronieʼs diseaseCurrent Opinion in Urology, 2001
- High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblastsEuropean Journal of Immunology, 2001
- The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblastsMolecular Pathology, 2001
- A RAT MODEL OF PEYRONIE’S DISEASE ASSOCIATED WITH A DECREASE IN ERECTILE ACTIVITY AND AN INCREASE IN INDUCIBLE NITRIC OXIDE SYNTHASE PROTEIN EXPRESSIONJournal of Urology, 2000
- THE EFFECT OF SURGICAL TRAUMA ON RAT TUNICA ALBUGINEAJournal of Urology, 1998
- AN ANIMAL MODEL OF PEYRONIE'S-LIKE CONDITION ASSOCIATED WITH AN INCREASE OF TRANSFORMING GROWTH FACTOR BETA mRNA AND PROTEIN EXPRESSIONJournal of Urology, 1997
- Proposal: Trauma as the Cause of the Peyronie's LesionJournal of Urology, 1997
- The Anatomy of the Tunica Albuginea in the Normal Penis and Peyronie's DiseaseJournal of Urology, 1997